Delivery Order SPE2DX22D0029-SPE2D825F36VM
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $11,379.98 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price contract is non-competitive and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at the contractor's corporate office...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on July 26, 2025, with ultimate completion by July 28, 2025. This firm fixed-price, non-set-aside delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $7,963.79 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The delivery order carries no set-aside designation...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,083.60 to AmerisourceBergen Drug Corp on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. The award was competitively granted with no set-aside designation, reflecting the...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $14,244.42 to AmerisourceBergen Drug Corp on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract involves no set-aside designation and was competitively...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,790.80 to AmerisourceBergen Drug Corp on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $94,955.58 to AmerisourceBergen Drug Corp on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $21,060.18 to AmerisourceBergen Drug Corp on July 28, 2025, for pharmaceutical and medical supply fulfillment. This competitively awarded, non-set-aside contract reflects a firm fixed-price delivery order structure and is scheduled for completion by July 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,073.41 to AmerisourceBergen Drug Corp on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award carries no set-aside designation, reflecting competitive procurement...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $7,169.99 to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The award is being fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania, and the specific...
- SPE2DX22D0029Indefinite Delivery Contract
- SPE2DX22D0029-SPE2D825F36VMDelivery Order
The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $7,983.12 to AmerisourceBergen Drug Corp on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime contractor, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location and supply pharmaceutical products and medical supplies to support federal military and healthcare operations. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order is one of numerous competitively awarded transactions the company fulfills under its DLA prime vendor agreement, which enables comprehensive pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. No set-aside designation was applied to this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 7/24/25 |